+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Microorganisms isolated from the corneal surface before and during topical cyclosporine treatment in dogs with keratoconjunctivitis sicca



Microorganisms isolated from the corneal surface before and during topical cyclosporine treatment in dogs with keratoconjunctivitis sicca



American Journal of Veterinary Research 56(7): 880-884



The effect that topical administration of cyclosporine would have on the number and type of microorganisms isolated from the corneal surface of dogs with keratoconjunctivitis sicca was studied. Schirmer tear tests were performed on and corneal swab specimens were collected from 61 eyes of 31 dogs with keratoconjunctivitis sicca prior to and after 3, 6, and 12 months of treatment with cyclosporine. In eyes that responded to cyclosporine treatment (Schirmer tear test value increased by gtoreq 5 mm/min, compared with pretreatment value), the percentage of eyes from which bacteria were isolated after 3, 6, and 12 months of treatment was significantly (P lt 0.001) less than the percentage from which bacteria were isolated prior to treatment. However, among eyes that did not respond to treatment, we did not detect a significant change over time in prevalence of bacteria or type of bacteria isolated. The percentage of eyes from which fungi were isolated decreased during treatment; however, the small number of eyes in which fungal culture results were initially positive precluded demonstration of a significant change. For all eyes, we did not detect any significant differences over time in the frequency with which specific bacterial genera were isolated, with the exception of beta-hemolytic Streptococcus spp. Opportunistic corneal infections were not detected even though none of the dogs received antibiotics. An increase in production of tears, which contain anti-infection proteins, was believed to be the primary factor responsible for the decrease in the percentage of eyes from which microorganisms could be isolated.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 002654696

Download citation: RISBibTeXText

PMID: 7574155


Related references

Keratoconjunctivitis sicca in dogs: Treatment with topical cyclosporine. Veterinary medicine reportng 2(2): 115-127, 1990

Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs. Journal of the American Veterinary Medical Association 199(8): 1043-1046, 1991

Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine. Veterinary Immunology and Immunopathology 49(3): 199-208, 1995

Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs. Journal of the American Veterinary Medical Association 199(8): 1039-1042, 1991

Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2 percent cyclosporine. Veterinary Immunology & Immunopathology 49(3): 199-208, 1995

Topical administration of petrolatum based cyclosporine for treatment of keratoconjunctivitis sicca in dogs. Journal of Veterinary Clinics 19(2): 260-263, 2002

Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine. Advances in Experimental Medicine and Biology 438: 997, 1998

Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine. Biotechnic and Histochemistry 90(3): 223-230, 2015

Topical cyclosporine therapy for keratoconjunctivitis sicca in dogs. Cornell Veterinarian 79(3): 207-209, 1989

Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca. American Journal of Veterinary Research 63(5): 688-694, 2002

Topical application of cyclosporine in the management of keratoconjunctivitis sicca in dogs. Journal of the American Animal Hospital Association 26(3): 269-274, 1990

Keratectomy for corneal pigmentation in dogs with cyclosporine responsive chronic keratoconjunctivitis sicca. Veterinary & Comparative Ophthalmology 5(1): 25-34, 1995

Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca. Klinische Monatsblatter für Augenheilkunde 229(5): 548-553, 2012

Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops. Archives of Ophthalmology 107(8): 1210-1216, 1989

Lymphocyte proliferation and blood drug levels in dogs with keratoconjunctivitis sicca receiving long-term topical ocular cyclosporine. Veterinary & Comparative Ophthalmology 6(2): 125-130, 1996